Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127643531 | 12764353 | 1 | I | 2010 | 20160908 | 20160920 | 20160920 | EXP | GB-TEVA-692705ACC | TEVA | 75.00 | YR | F | Y | 0.00000 | 20160921 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127643531 | 12764353 | 1 | PS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | 2.5 MILLIGRAM DAILY; | Y | U | 19982 | 2.5 | MG | TABLET | QD | |||||
| 127643531 | 12764353 | 2 | SS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | .5 DOSAGE FORMS DAILY; | Y | U | 19982 | .5 | DF | TABLET | QD | |||||
| 127643531 | 12764353 | 3 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | 0 | ||||||||||||
| 127643531 | 12764353 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127643531 | 12764353 | 5 | C | CANDESARTAN | CANDESARTAN | 1 | 0 | ||||||||||||
| 127643531 | 12764353 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127643531 | 12764353 | 7 | C | WARFARIN | WARFARIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127643531 | 12764353 | 1 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127643531 | 12764353 | DE |
| 127643531 | 12764353 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127643531 | 12764353 | Death | |
| 127643531 | 12764353 | Leukaemia | |
| 127643531 | 12764353 | Off label use | |
| 127643531 | 12764353 | Pain in extremity | |
| 127643531 | 12764353 | Peripheral coldness | |
| 127643531 | 12764353 | Peripheral swelling | |
| 127643531 | 12764353 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127643531 | 12764353 | 1 | 2006 | 2010 | 0 | |
| 127643531 | 12764353 | 2 | 2010 | 2011 | 0 |